intelligence360
  • SUBSCRIBE
  • About us
  • Video News Daily
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

SmarterDx Embarks on Next Phase of Growth and Product Innovation with New Mountain Capital

SmarterDx Embarks on Next Phase of Growth and Product Innovation with New Mountain Capital

April 15, 2025 Craig Etkin

Investment will accelerate the expansion of SmarterDx’s clinical AI platform, driving additional revenue integrity solutions and value for hospitals and health systems

NEW YORK–(BUSINESS WIRE)–SmarterDx, Inc. (“SmarterDx” or “the Company”), a leader in clinical AI for revenue integrity and care quality, today announced a strategic investment from New Mountain Capital, LLC (“New Mountain Capital”), a leading growth-oriented investment firm with more than $55 billion in assets under management. This investment will support SmarterDx’s next phase of growth and product innovation, focused on creating value for health systems and enabling them to deliver the best care for patients.

Founded in 2020 by Drs. Michael Gao and Joshua Geleris, SmarterDx is a proprietary clinical AI platform that helps hospitals analyze 100% of discharges, ensuring that each patient’s care is accurately captured and preventing any gaps in revenue integrity. The Company’s SmarterPrebill™ solution gives clinical documentation integrity (CDI) and coding teams the ability to validate every detail of patient care, helping hospitals recover millions in earned revenue while boosting care quality scores, while SmarterDenials™ gives them a faster, more effective way to overturn denials and recover lost revenue.

With New Mountain Capital’s growth investment, SmarterDx will continue to bolster its technology and AI platform, while accelerating the existing product roadmap and developing complementary solutions. SmarterDx delivers a Day One, 5:1 ROI across some of the largest hospitals and health systems across the U.S. The Company has quickly established itself as a leading healthcare revenue cycle solutions provider with over 40 leading health systems spanning 180 hospital sites joining its clinical AI platform. SmarterDx was also recognized as one of Modern Healthcare’s 2024 “Best in Business” in the Newcomer – Startups category.

“This strategic investment marks a pivotal moment in our journey to scale our AI platform and build new products that further helps capture hospitals’ differential – whether that’s in earned revenue, care quality, or operational efficiency,” said Dr. Michael Gao, Co-Founder and CEO of SmarterDx. “At SmarterDx, we believe that the most accurate and complete patient story is not just good documentation practice – it is an essential data layer that drives all aspects of healthcare. We are looking forward to having a partner in New Mountain Capital that shares our belief and will enable us to further strengthen our capabilities to support health systems and their patients.”

“Our north star is to help hospitals, and this will accelerate our ability to build AI solutions that drive real outcomes. There is a lot more to come, and we are incredibly excited for this next chapter where we can deliver even greater innovation,” said Dr. Joshua Geleris, Co-Founder and Head of Product and Data Science at SmarterDx.

“We have been deeply impressed by the SmarterDx platform and the physician-led team that Dr. Gao and Dr. Geleris have built. Their commitment to hospitals and health systems is remarkable, and we are excited to support what we think is one of the best teams in the health tech sector,” said Matt Holt, Managing Director and President, Private Equity, at New Mountain Capital. “New Mountain’s investment in SmarterDx comes off the back of our multi-year investment focus on the convergence of clinical and administrative workflows. We are excited to support SmarterDx as a major platform company focused on delivering high strategic value to healthcare providers.”

The transaction is subject to customary regulatory approvals and is expected to close in the second quarter of this year. Cooley LLP served as legal advisor and J.P. Morgan Securities LLC served as financial advisor to SmarterDx. Ropes & Gray LLP served as legal advisor to New Mountain Capital.

About SmarterDx

SmarterDx builds clinical AI that empowers hospitals to analyze the complete record of every patient to fully capture the value of care delivered. Founded by physicians in 2020, its proprietary AI platform understands the nuances of clinical reasoning, enabling hospitals to true the patient record for every discharge. By doing so, hospitals can recover millions in earned revenue, enhance care quality metrics, and optimize healthcare operations. For more information, visit: https://www.smarterdx.com/.

About New Mountain Capital

New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than excessive risk, as it pursues long-term capital appreciation. The firm currently manages private equity, strategic equity, credit, and net lease real estate funds with over $55 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information, visit: www.newmountaincapital.com.

Contacts

New Mountain Capital
Dana Gorman / Lisa Pham
H/Advisors Abernathy for New Mountain Capital
dana.gorman@h-advisors.global / lisa.pham@h-advisors.global

(c)2025 Business Wire, Inc., All rights reserved.


Venture Capital
Business Wire, New York, SmarterDx, Venture Capital

Post navigation

NEXT
Portland Oregon Metro based Atlas Laboratories, Inc. has secured $2,835,000.00 in new commercial capital.
PREVIOUS
The Ryl Company Secures $15 Million in Series B Funding to Fuel Nationwide Expansion and Product Development
Comments are closed.
Subscribe for FREE!

intelligence360

intelligence360
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Kimberly-Clark Corporation, one of the world's leading manufacturers of personal care and hygiene products, will establish an $800 million advanced manufacturing facility in Trumbull County, bringing an anticipated 491 new high-quality jobs. For Kimberly-Clark, this new facility would be its first in Ohio and represents not just a strategic expansion, but a decisive step in doubling down on growth in the American market. Spread across more than one million square feet, the Warren facility will provide the manufacturing capacity needed to unleash future growth for Kimberly-Clark’s fastest-growing personal care categories that include Baby & Child Care and Adult & Feminine Care. Warren is in geographic proximity to roughly 117 million consumers and will serve as a strategic hub for the Northeast and Midwest regions. Construction is expected to begin this month and will take up to two years.

In a statement Tamera Fenske, chief supply chain officer at Kimberly-Clark said, “Our investment in Warren is a pivotal step forward in our North America business and strategy.” “By establishing a new, state-of-the-art manufacturing facility in Ohio, we’re enhancing our ability to serve millions of consumers across the Midwest and Northeast with greater speed, agility, and resilience. It’s a once-in-a-career opportunity to build a facility from the ground up that reflects the future of manufacturing, and with the support of local partners like JobsOhio, the Department of Development, Lake to River, Western Reserve Port Authority, and local governments, we have the unique opportunity to create high-quality jobs and long-term economic impact in the region.”

Based in Dallas and employing 46,000 people in 34 countries, the company’s portfolio of brands also includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll. Its products are sold in more than 175 countries and territories.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Snorkel AI announced general availability of two new product offerings on the Snorkel AI Data Development Platform: Snorkel Evaluate and Snorkel Expert Data-as-a-Service. These launches advance its mission to turn knowledge into specialized AI—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. In addition, Snorkel AI announced it has raised $100 million in Series D funding at a $1.3 billion valuation, led by Addition. This new funding will fuel continued research and innovation in evaluating and tuning specialized AI systems with expert data.


In a statement Alex Ratner, Co-founder and CEO of Snorkel AI said, “We are seeing a surge of momentum around agentic AI, but specialized enterprise agents aren’t ready for production in most settings.” “Enterprises need domain-specific data and expertise to make this a reality. We’re excited to deliver on this need and help AI innovators develop expert data to bring their LLM and agentic systems into production with our new offerings, which round out Snorkel’s unified AI data development stack.”

Snorkel AI is building the Snorkel AI Data Development Platform for evaluating and tuning specialized AI at scale. Snorkel AI’s offerings, including Snorkel Evaluate and Snorkel Expert Data-as-a-Service, accelerate evaluation and tuning of specialized AI systems with expert data—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. Launched out of the Stanford AI Lab, Snorkel AI’s platform is used in production by Fortune 500 companies, including BNY, Wayfair, and Chubb, as well as across the U.S. federal government, including the U.S. Air Force.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

TicketManager, a global leader in event ticket and guest management solutions for the corporate enterprise, today announced Valeas Capital Partners, a growth-oriented private-equity firm, has acquired a majority stake in the company. Under the terms of the agreement, Valeas is committing $110 million to support TicketManager’s strategic growth plans. TicketManager Co-Founder and CEO Tony Knopp and COO Ken Hanscom will retain a minority interest in the Company. Founded in 2007, TicketManager is the category leader in providing software and services to manage end-to-end event ticket workflow and guest experiences. Serving as the central hub and system of record for data-driven organizations, the platform streamlines every step of the ticket management process. Every year, companies spend more than $600 billion on customer entertainment, yet 43% of corporate tickets are never used and fewer than 20% of organizations leverage modern software to optimize those investments and mitigate compliance risk.

In a statement Tony Knopp, CEO and Co-Founder of TicketManager said, “Live events are an important investment for businesses of all sizes. Whether major global sponsorships, naming rights for stadiums, luxury suites or even a few season tickets for the local team, companies use them to attract and keep customers while building their brands. But in today’s market, many companies struggle with growing pressure to show the value of their ticket spending.” “We knew there was a better way, and that’s why we created TicketManager – to make company tickets easy and prove the return on investment with cutting edge technology and services.”

TicketManager is a leading event- and guest-management platform that empowers companies to make client entertainment easy and drive greater return on investment. It offers convenient and simple technology to manage corporate sports and entertainment tickets, create exceptional guest life-cycle experiences, and measure effectiveness. TicketManager is trusted by more than 500 global brands including Verizon, FedEx, Adidas, Anheuser-Busch, and Mastercard.
Load More... Subscribe

Categories

Recent Posts

  • Bespoken Spirits Announces Successful Close of Series-C Funding Round June 9, 2025
  • Bito Raises $5.7M Seed Extension to Expand AI Code Review Platform with Codebase Awareness June 9, 2025
  • Pillar Biosciences Raises $34.5M in Funding June 9, 2025
  • CloudZero Raises $56M Series C To Redefine Cloud Cost Optimization In The AI Era June 9, 2025

Archives

© 2025   Copyright SI360 Inc. All Rights Reserved.